Macquarie Group’s Zymeworks ZYME Stock Holding History

Macquarie Group’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-871	Closed	-$6	–	2636
2022 Q1	$6	Hold	871	–	–	﹤0.01%	2584
2021 Q4	$14K	Hold	871	–	–	﹤0.01%	2470
2021 Q3	$25K	Hold	871	–	–	﹤0.01%	2407
2021 Q2	$30K	Hold	871	–	–	﹤0.01%	2276
2021 Q1	$28K	Sell	871 -21,690	-96%	-$881K	﹤0.01%	2213
2020 Q4	$1.07M	Sell	22,561 -1,701	-7%	-$79K	﹤0.01%	1296
2020 Q3	$1.13M	Sell	24,262 -860	-3%	-$29.5K	﹤0.01%	1210
2020 Q2	$906K	Buy	25,122 +4,975	+25%	+$183K	﹤0.01%	1230
2020 Q1	$715K	Buy	+20,147	New	+$825K	﹤0.01%	1181
2019 Q1	–	Sell	-1,306	Closed	-$19K	–	2067
2018 Q4	$19K	Sell	1,306 -14	-1%	-$184	﹤0.01%	1808
2018 Q3	$21K	Buy	+1,320	New	+$18.9K	﹤0.01%	1899
2018 Q1	–	Sell	-600	Closed	-$5K	–	2383
2017 Q4	$5K	Buy	+600	New	+$4.93K	﹤0.01%	2345

Other funds holding ZYME

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Macquarie Group's ZYME Position: Q2 2022 in Review

Macquarie Group sold out of Zymeworks (ZYME) in Q2 2022, closing a stake of 871 shares — an estimated $6 sold.

Macquarie Group first reported a position in ZYME in Q4 2017 and held it in 12 quarters. The position peaked at $1.13M in Q3 2020. 113 funds tracked by Wall St. Rank hold ZYME as of Q2 2022.

Macquarie Group reported no remaining Zymeworks position as of Q2 2022 after selling out during the quarter.
Macquarie Group sold 871 Zymeworks shares in Q2 2022, an estimated $6.
Macquarie Group first reported a position in Zymeworks in Q4 2017 and held it in 12 quarters.
Macquarie Group's Zymeworks position peaked at $1.13M in Q3 2020.
113 funds tracked by Wall St. Rank held Zymeworks as of Q2 2022.

Based on Macquarie Group's 13F filing for Q2 2022, filed 15 Aug 2022.